vs
Side-by-side financial comparison of ENERGIZER HOLDINGS, INC. (ENR) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
PERRIGO Co plc is the larger business by last-quarter revenue ($1.1B vs $778.9M, roughly 1.4× ENERGIZER HOLDINGS, INC.). ENERGIZER HOLDINGS, INC. runs the higher net margin — 1.3% vs -127.8%, a 129.1% gap on every dollar of revenue. On growth, PERRIGO Co plc posted the faster year-over-year revenue change (-2.5% vs -3.0%). ENERGIZER HOLDINGS, INC. produced more free cash flow last quarter ($2.0B vs $148.6M). Over the past eight quarters, ENERGIZER HOLDINGS, INC.'s revenue compounded faster (5.4% CAGR vs 1.3%).
Energizer Holdings, Inc. is an American manufacturer and one of the world's largest manufacturers of batteries, headquartered in Clayton, Missouri. It produces batteries under the Energizer, Ray-O-Vac, Varta, and Eveready brand names and formerly owned several personal care businesses until it separated that side of the business into a new company called Edgewell Personal Care in 2015.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
ENR vs PRGO — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $778.9M | $1.1B |
| Net Profit | $10.1M | $-1.4B |
| Gross Margin | 33.2% | 32.6% |
| Operating Margin | — | -116.0% |
| Net Margin | 1.3% | -127.8% |
| Revenue YoY | -3.0% | -2.5% |
| Net Profit YoY | -64.3% | -3093.9% |
| EPS (diluted) | $0.15 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $778.9M | — | ||
| Q4 25 | $778.9M | $1.1B | ||
| Q3 25 | $832.8M | $1.0B | ||
| Q2 25 | $725.3M | $1.1B | ||
| Q1 25 | $662.9M | $1.0B | ||
| Q4 24 | $731.7M | $1.1B | ||
| Q3 24 | $805.7M | $1.1B | ||
| Q2 24 | $701.4M | $1.1B |
| Q1 26 | $10.1M | — | ||
| Q4 25 | $-3.4M | $-1.4B | ||
| Q3 25 | $34.9M | $7.5M | ||
| Q2 25 | $153.5M | $-8.4M | ||
| Q1 25 | $28.3M | $-6.4M | ||
| Q4 24 | $22.3M | $-44.4M | ||
| Q3 24 | $47.6M | $-21.0M | ||
| Q2 24 | $-43.8M | $-108.4M |
| Q1 26 | 33.2% | — | ||
| Q4 25 | 32.9% | 32.6% | ||
| Q3 25 | 36.6% | 36.1% | ||
| Q2 25 | 55.1% | 34.4% | ||
| Q1 25 | 39.1% | 37.6% | ||
| Q4 24 | 36.8% | 33.9% | ||
| Q3 24 | 38.1% | 37.2% | ||
| Q2 24 | 39.5% | 37.0% |
| Q1 26 | — | — | ||
| Q4 25 | -0.6% | -116.0% | ||
| Q3 25 | 6.4% | 7.0% | ||
| Q2 25 | 22.6% | 4.3% | ||
| Q1 25 | 5.5% | 4.5% | ||
| Q4 24 | 4.1% | 10.0% | ||
| Q3 24 | 7.4% | 7.4% | ||
| Q2 24 | -8.2% | -2.5% |
| Q1 26 | 1.3% | — | ||
| Q4 25 | -0.4% | -127.8% | ||
| Q3 25 | 4.2% | 0.7% | ||
| Q2 25 | 21.2% | -0.8% | ||
| Q1 25 | 4.3% | -0.6% | ||
| Q4 24 | 3.0% | -3.9% | ||
| Q3 24 | 5.9% | -1.9% | ||
| Q2 24 | -6.2% | -10.2% |
| Q1 26 | $0.15 | — | ||
| Q4 25 | — | $-10.23 | ||
| Q3 25 | — | $0.05 | ||
| Q2 25 | — | $-0.06 | ||
| Q1 25 | — | $-0.05 | ||
| Q4 24 | — | $-0.32 | ||
| Q3 24 | — | $-0.15 | ||
| Q2 24 | — | $-0.79 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $172.5M | — |
| Total DebtLower is stronger | $3.3B | — |
| Stockholders' EquityBook value | $173.2M | $2.9B |
| Total Assets | $4.4B | $8.5B |
| Debt / EquityLower = less leverage | 19.13× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $172.5M | — | ||
| Q4 25 | $214.8M | — | ||
| Q3 25 | $236.2M | $432.1M | ||
| Q2 25 | $171.1M | $454.2M | ||
| Q1 25 | $139.3M | $409.9M | ||
| Q4 24 | $195.9M | $558.8M | ||
| Q3 24 | $216.9M | $1.5B | ||
| Q2 24 | $146.7M | $542.8M |
| Q1 26 | $3.3B | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $3.4B | — | ||
| Q2 25 | $3.2B | — | ||
| Q1 25 | $3.2B | — | ||
| Q4 24 | $3.1B | — | ||
| Q3 24 | $3.2B | — | ||
| Q2 24 | $3.2B | — |
| Q1 26 | $173.2M | — | ||
| Q4 25 | $141.3M | $2.9B | ||
| Q3 25 | $169.9M | $4.4B | ||
| Q2 25 | $183.2M | $4.5B | ||
| Q1 25 | $133.9M | $4.4B | ||
| Q4 24 | $140.6M | $4.3B | ||
| Q3 24 | $135.8M | $4.6B | ||
| Q2 24 | $123.4M | $4.5B |
| Q1 26 | $4.4B | — | ||
| Q4 25 | $4.4B | $8.5B | ||
| Q3 25 | $4.6B | $10.1B | ||
| Q2 25 | $4.5B | $10.1B | ||
| Q1 25 | $4.2B | $9.8B | ||
| Q4 24 | $4.2B | $9.6B | ||
| Q3 24 | $4.3B | $11.2B | ||
| Q2 24 | $4.2B | $10.4B |
| Q1 26 | 19.13× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 20.28× | — | ||
| Q2 25 | 17.57× | — | ||
| Q1 25 | 23.56× | — | ||
| Q4 24 | 22.17× | — | ||
| Q3 24 | 23.51× | — | ||
| Q2 24 | 26.04× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $175.4M |
| Free Cash FlowOCF − Capex | $2.0B | $148.6M |
| FCF MarginFCF / Revenue | 260.1% | 13.4% |
| Capex IntensityCapex / Revenue | 5.5% | 2.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $2.2B | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $149.5M | $175.4M | ||
| Q3 25 | $61.5M | $51.7M | ||
| Q2 25 | $21.4M | $75.9M | ||
| Q1 25 | $-12.8M | $-64.5M | ||
| Q4 24 | $77.0M | $312.6M | ||
| Q3 24 | $168.9M | $42.2M | ||
| Q2 24 | $45.8M | $9.5M |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $124.2M | $148.6M | ||
| Q3 25 | $46.7M | $29.8M | ||
| Q2 25 | $7.9M | $56.7M | ||
| Q1 25 | $-33.8M | $-90.0M | ||
| Q4 24 | $42.4M | $274.9M | ||
| Q3 24 | $141.5M | $15.1M | ||
| Q2 24 | $27.3M | $-18.9M |
| Q1 26 | 260.1% | — | ||
| Q4 25 | 15.9% | 13.4% | ||
| Q3 25 | 5.6% | 2.9% | ||
| Q2 25 | 1.1% | 5.4% | ||
| Q1 25 | -5.1% | -8.6% | ||
| Q4 24 | 5.8% | 24.2% | ||
| Q3 24 | 17.6% | 1.4% | ||
| Q2 24 | 3.9% | -1.8% |
| Q1 26 | 5.5% | — | ||
| Q4 25 | 3.2% | 2.4% | ||
| Q3 25 | 1.8% | 2.1% | ||
| Q2 25 | 1.9% | 1.8% | ||
| Q1 25 | 3.2% | 2.4% | ||
| Q4 24 | 4.7% | 3.3% | ||
| Q3 24 | 3.4% | 2.5% | ||
| Q2 24 | 2.6% | 2.7% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 1.76× | 6.89× | ||
| Q2 25 | 0.14× | — | ||
| Q1 25 | -0.45× | — | ||
| Q4 24 | 3.45× | — | ||
| Q3 24 | 3.55× | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ENR
Segment breakdown not available.
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
